NCT03541564View on ClinicalTrials.gov

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions
Systemic Lupus ErythematosusHealthy Participants
Interventions
DRUG

BMS-986165

Specified dose on specified days

DRUG

Moxifloxacin

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (1)

66219

PRA Health Sciences, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03541564 - An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects | Biotech Hunter | Biotech Hunter